Market Overview

UPDATE: Topeka Capital Markets Upgrades Monsanto to Buy on Improved Risk Profile

Related MON
Monsanto: Morgan Stanley Still Likes Stock, But Cuts Target
Morning Market Losers
Explaining Returns On Dividend-Paying Large-Cap Tech And Industrial Stocks (Seeking Alpha)

Topeka Capital Markets raised its rating on Monsanto (NYSE: MON) from Hold to Buy with a $107 price target.

Topeka Capital Markets said, "When initiating coverage with a Hold rating in Sept., we acknowledged MON's positive commercial momentum, and anticipated positive Ag fundamentals – particularly in corn –would remain a favorable tailwind for the Company. These aspects of the MON story remain intact. Our cautiousness was based primarily on perceptions regarding questions about the diminishing effectiveness of certain biotech traits, which could ultimately undermine MON's valuation, along with perceived uncertainty regarding the impending expiration of MON's RR patent in 2014. We now believe these potential issues could be less acute, if not benign, at least in the relatively near-term."

Monsanto closed at $88.42 on Monday.

Latest Ratings for MON

Oct 2015JP MorganAssumesNeutral
Aug 2015Morgan StanleyAssumesOverweight
Aug 2015Canaccord GenuityMaintainsBuy

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Topeka Capital MarketsAnalyst Color Upgrades Intraday Update Analyst Ratings


Related Articles (MON)

View Comments and Join the Discussion!

Get Benzinga's Newsletters